Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP522100.RA53rUOYLKjM06Hfnp1qjM1Ek6dzl_dVixnVOwf9MQOzg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP522100.RA53rUOYLKjM06Hfnp1qjM1Ek6dzl_dVixnVOwf9MQOzg130_assertion type Assertion NP522100.RA53rUOYLKjM06Hfnp1qjM1Ek6dzl_dVixnVOwf9MQOzg130_head.
- NP522100.RA53rUOYLKjM06Hfnp1qjM1Ek6dzl_dVixnVOwf9MQOzg130_assertion description "[Since data on levels of inflammatory proteins and/or active factors in FH patients who have never received lipid-lowering treatment are lacking, serum levels of MMP-3, active MMP-9 and TIMP-1 as well as pro-inflammatory cytokines (TNF-alpha, IL-18) were determined in never-treated homozygous FH Moroccan patients (n=4) and compared to those of heterozygous FH subjects (n=7) and of healthy control subjects (n=5).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP522100.RA53rUOYLKjM06Hfnp1qjM1Ek6dzl_dVixnVOwf9MQOzg130_provenance.
- NP522100.RA53rUOYLKjM06Hfnp1qjM1Ek6dzl_dVixnVOwf9MQOzg130_assertion evidence source_evidence_literature NP522100.RA53rUOYLKjM06Hfnp1qjM1Ek6dzl_dVixnVOwf9MQOzg130_provenance.
- NP522100.RA53rUOYLKjM06Hfnp1qjM1Ek6dzl_dVixnVOwf9MQOzg130_assertion SIO_000772 16280123 NP522100.RA53rUOYLKjM06Hfnp1qjM1Ek6dzl_dVixnVOwf9MQOzg130_provenance.
- NP522100.RA53rUOYLKjM06Hfnp1qjM1Ek6dzl_dVixnVOwf9MQOzg130_assertion wasDerivedFrom befree-2016 NP522100.RA53rUOYLKjM06Hfnp1qjM1Ek6dzl_dVixnVOwf9MQOzg130_provenance.
- NP522100.RA53rUOYLKjM06Hfnp1qjM1Ek6dzl_dVixnVOwf9MQOzg130_assertion wasGeneratedBy ECO_0000203 NP522100.RA53rUOYLKjM06Hfnp1qjM1Ek6dzl_dVixnVOwf9MQOzg130_provenance.